The public consultation process on the draft Vaccine Supply and Procurement Strategy 2011-2015 is now closed. Thank you to all who have provided feedback.
What was the outcome of the public consultation?
The consultation generated significant interest: there were over 620 visits to the Gavi website and over 230 visits to the feedback form specifically. In total, 15 feedback forms were submitted from individual respondents and those representing a broader constituency: individuals (6 responses), donors (4), civil society (4), and pharmaceutical industry (1).
An overview of the process, as well as a summary of the main themes that emerged from the comments received is available here.
What will Gavi do with the comments?
All comments submitted through the online form have been reviewed, compiled and incorporated as appropriate into a revised version of the Supply and Procurement Strategy. This revised version as well as the consolidated comments and feedback received during this consultation process will be presented to the Programme and Policy Committee (PPC) of the Gavi Board in September for review and further comments. The PPC will then present the strategy to the Board for final review and decision in November 2011.
Why does Gavi need a supply and procurement strategy and what is the scope?
The Vaccine Alliance’s success in saving children’s lives and protecting people’s health requires an adequate supply of appropriate, quality vaccines at minimised cost for Gavi and countries.
In order to actively influence vaccine markets to meet these objectives the Vaccine Alliance needs a comprehensive strategy that recognises the differences across vaccines in terms of market maturity and competition, manufacturing complexity and the Vaccine Alliance’s relative market power, as measured by revenues and volumes relative to other purchasers.
The draft document which was open for public consultation laid out the objectives of the new supply and procurement strategy and proposed the means to achieve them. It focused on the period defined by the Gavi's five-year strategic plan (2011-2015).
However, it is recognised that the proposed measures will have an impact beyond 2015. The strategy applies to vaccines that have been recommended or will be recommended for use in Gavi-eligible countries and does not address issues related to vaccine-related supplies (e.g. syringes, safety boxes) or in-country supply chain management.
What was the process to date to develop the current draft of the new strategy?
The strategy review process was steered by a task team, under the oversight of the Programme and Policy Committee, composed of 10 experts in the field of vaccine supply and procurement. The final recommendations of the task team were presented to the PPC in May 2011 and the feedback by PPC members has been integrated into the draft strategy that was available for consultation.
With the consultation now closed, the Gavi Secretariat is revising the draft strategy based on comments received during the consultation. The revised version, together with detailed comments and consolidated comments received, will be presented to the PPC on 29 September.